Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus

American Journal of Cardiology

Volumn 112, Issue 4, 2013, Pages 499-504

  Valbusa, Filippo ^a   Bertolini, Lorenzo ^a   Bonapace, Stefano ^a   Zenari, Luciano ^a   Zoppini, Giacomo ^b   Arcaro, Guido ^a   Byrne, Christopher D ^c,d   Targher, Giovanni ^b  

^a SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; SARTAN DERIVATIVE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; DIABETIC PATIENT; ELECTROCARDIOGRAPHY; FEMALE; FRAMINGHAM RISK SCORE; GENDER; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; ITALY; LIPIDS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK; RISK FACTORS; URIC ACID;

EID: 84881145969     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.04.012     Document Type: Article

References (30)

1. D.I. Feig, D.H. Kang, and R.J. Johnson Uric acid and cardiovascular risk N Engl J Med 359 2008 1811 1821
2. G. Lippi, M. Montagnana, M. Franchini, E.J. Favaloro, and G. Targher The paradoxical relationship between serum uric acid and cardiovascular disease Clin Chim Acta 392 2008 1 7
3. M.M. Hoeper, J.M. Hohlfeld, and H. Fabel Hyperuricaemia in patients with right or left heart failure Eur Respir J 13 1999 682 685
4. C. Chrysohoou, C. Pitsavos, J. Barbetseas, S. Brili, I. Kotroyiannis, L. Papademetriou, G. Metallinos, J. Skoumas, C. Tentolouris, and C. Stefanadis Serum uric acid levels correlate with left atrial function and systolic right ventricular function in patients with newly diagnosed heart failure: the hellenic heart failure study Congest Heart Fail 14 2008 229 233
5. K.P. Letsas, P. Korantzopoulos, G.S. Filippatos, C.C. Mihas, V. Markou, G. Gavrielatos, M. Efremidis, A. Sideris, and F. Kardaras Uric acid elevation in atrial fibrillation Hellenic J Cardiol 51 2010 209 213
6. T. Liu, X. Zhang, P. Korantzopoulos, S. Wang, and G. Li Uric acid levels and atrial fibrillation in hypertensive patients Intern Med 50 2011 799 803
7. Y. Liu, H. Liu, L. Dong, J. Chen, and J. Guo Prevalence of atrial fibrillation in hospitalized patients over 40 years old: ten-year data from the People's Hospital of Peking University Acta Cardiol 65 2010 221 224
8. S. Suzuki, K. Sagara, T. Otsuka, S. Matsuno, R. Funada, T. Uejima, Y. Oikawa, A. Koike, K. Nagashima, H. Kirigaya, J. Yajima, H. Sawada, T. Aizawa, and T. Yamashita Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence Circ J 76 2012 607 611
9. L. Tamariz, S. Agarwal, E.Z. Soliman, A.M. Chamberlain, R. Prineas, A.R. Folsom, M. Ambrose, and A. Alonso Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] study) Am J Cardiol 108 2011 1272 1276
10. K.P. Letsas, C.H. Siklódy, P. Korantzopoulos, R. Weber, G. Bürkle, C.C. Mihas, D. Kalusche, and T. Arentz The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation Int J Cardiol 164 2013 94 98
11. X.N. He, S.N. Li, J.L. Zhan, S.L. Xie, Z.J. Zhang, J.Z. Dong, R.H. Yu, D.Y. Long, R.B. Tang, and C.S. Ma Serum uric acid levels correlate with recurrence of paroxysmal atrial fibrillation after catheter ablation Chin Med J (Engl) 126 2013 860 864
12. G.A. Nichols, K. Reinier, and S.S. Chugh Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation Diabetes Care 32 2009 1851 1856
13. A.P. Vanezis, and R. Bhopal Validity of electrocardiographic classification of left ventricular hypertrophy across adult ethnic groups with echocardiography as a standard J Electrocardiol 41 2008 404 412
14. L.A. Stevens, J. Coresh, T. Greene, and A.S. Levey Assessing kidney function - measured and estimated glomerular filtration rate N Engl J Med 354 2006 2473 2483
15. R.B. Schnabel, L.M. Sullivan, D. Levy, M.J. Pencina, J.M. Massaro, R.B. D'Agostino Sr., C. Newton-Cheh, J.F. Yamamoto, J.W. Magnani, T.M. Tadros, W.B. Kannel, T.J. Wang, P.T. Ellinor, P.A. Wolf, R.S. Vasan, and E.J. Benjamin Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study Lancet 373 2009 739 745
16. D.I. Jalal, M. Chonchol, W. Chen, and G. Targher Uric acid as a target of therapy in chronic kidney disease Am J Kidney Dis 61 2013 134 146
17. Q.Y. Zhao, S.B. Yu, H. Huang, H.Y. Cui, M. Qin, T. Huang, and C.X. Huang Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure Chin Med J (Engl) 125 2012 1708 1712
18. G.Y. Lip, H.F. Tse, and D.A. Lane Atrial fibrillation Lancet 379 2012 648 661
19. A.M. Chamberlain, S.K. Agarwal, A.R. Folsom, E.Z. Soliman, L.E. Chambless, R. Crow, M. Ambrose, and A. Alonso A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study) Am J Cardiol 107 2011 85 91
20. R.J. Aviles, D.O. Martin, C. Apperson-Hansen, P.L. Houghtaling, P. Rautaharju, R.A. Kronmal, R.P. Tracy, D.R. Van Wagoner, B.M. Psaty, M.S. Lauer, and M.K. Chung Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
21. Y. Guo, G.Y. Lip, and S. Apostolakis Inflammation in atrial fibrillation J Am Coll Cardiol 60 2012 2263 2270
22. S.C. Dudley Jr., N.E. Hoch, L.A. McCann, C. Honeycutt, L. Diamandopoulos, T. Fukai, D.G. Harrison, S.I. Dikalov, and J. Langberg Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases Circulation 112 2005 1266 1273
23. M.J. Mihm, F. Yu, C.A. Carnes, P.J. Reiser, P.M. McCarthy, D.R. Van Wagoner, and J.A. Bauer Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation Circulation 104 2011 174 180
24. D.H. Kang, L. Han, X. Ouyang, A.M. Kahn, J. Kanellis, P. Li, L. Feng, T. Nakagawa, S. Watanabe, M. Hosoyamada, H. Endou, M. Lipkowitz, R. Abramson, W. Mu, and R.J. Johnson Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter Am J Nephrol 25 2005 425 433
25. J. Kanellis, S. Watanabe, J.H. Li, D.H. Kang, P. Li, T. Nakagawa, A. Wamsley, D. Sheikh-Hamad, H.Y. Lan, L. Feng, and R.J. Johnson Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2 Hypertension 41 2003 1287 1293
26. W. Baldwin, S. McRae, G. Marek, D. Wymer, V. Pannu, C. Baylis, R.J. Johnson, and Y.Y. Sautin Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome Diabetes 60 2011 1258 1269
27. G. Mercuro, C. Vitale, E. Cerquetani, S. Zoncu, M. Deidda, M. Fini, and G.M. Rosano Effect of hyperuricaemia upon endothelial function in patients at increased cardiovascular risk Am J Cardiol 94 2004 932 935
28. R. Butler, A.D. Morris, J.J. Belch, A. Hill, and A.D. Struthers Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension Hypertension 35 2000 746 751
29. N.S. Rajendra, S. Ireland, J. George, J.J. Belch, C.C. Lang, and A.D. Struthers Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris J Am Coll Cardiol 58 2011 820 828
30. W. Doehner, N. Schoene, M. Rauchhaus, F. Leyva-Leon, D.V. Pavitt, D.A. Reaveley, G. Schuler, A.J. Coats, S.D. Anker, and R. Hambrecht Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies Circulation 105 2002 2619 2624